QRP Research Tirzepatide – 15 mg
 
Tirzepatide is a research-grade peptide supplied by QRP Research for laboratory and analytical research applications.
 
Tirzepatide is a synthetic peptide of interest in controlled GIP and GLP-1 receptor-related research, molecular characterisation and stability studies.
Each vial contains 15 mg of Tirzepatide and is intended strictly for qualified research purposes.
 
Independent Laboratory Tested
The current batch has been independently analysed by MZ Biolabs using HPLC-UV-MS methodology.
 
Laboratory analysis confirmed:
Purity: 99.98%
Identity confirmed by HPLC-MS
Expected monoisotopic mass: 4810.52 Da
Measured monoisotopic mass: 4810.60 Da
Lot / Batch: 2026-07-13
Analysis date: 24 Jul 2026
Mass spectrometry analysis confirmed the molecular identity of the tested material, while HPLC analysis recorded the stated principal-peak purity for the tested batch.
 
Product Details
Product: Tirzepatide
Content: 15 mg
Form: Research peptide
Purity: 99.98% – current tested batch
Testing Method: HPLC-UV-MS
Research Category: Peptide research
Supplier: QRP Research
 
Quality & Verification
At QRP Research, analytical verification forms an important part of our quality-control process. Where available, products are supported by independent analytical testing to confirm both compound identity and chromatographic purity.
A Certificate of Analysis for this batch is available for review.
 
FOR RESEARCH USE ONLY.
This product is supplied exclusively for laboratory, analytical and scientific research purposes. It is not intended for human or veterinary use, consumption, diagnosis, treatment, prevention or mitigation of any disease or medical condition.
Purchasers are responsible for ensuring that the product is handled, stored and used in accordance with all applicable laws, regulations and laboratory safety procedures.
QRP Research – Precision. Verification. Research.